<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antibodies directed against protein S (anti-ProtS) may be involved in the development of <z:mp ids='MP_0005048'>thrombosis</z:mp> in patients with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We assessed the prevalence and clinical significance of anti-ProtS and evaluated their immunological characteristics in 184 patients with SLE and 99 healthy donors </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were tested for IgG anti-ProtS by an in-house ELISA </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma levels and functional activity of protein S were also tested </plain></SENT>
<SENT sid="4" pm="."><plain>Anti-ProtS were found in 57 patients (31%) and 4 healthy controls (4%) </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> had anti-ProtS more frequently than controls (29% vs 4%, OR 9.5 [95% CI 3.07-29.3], p&lt;0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>Anti-ProtS were more frequent in patients with <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and in those with <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, than in controls (41% vs. 4%, OR 16.5 [95% CI 5-54], p&lt;0.0001 and 23% vs. 4%, OR 7 [95%CI 2.1-23.5], p=0.0008, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with <z:e sem="disease" ids="C0728731" disease_type="Disease or Syndrome" abbrv="">prematurity</z:e>, <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> and <z:hpo ids='HP_0001511'>intrauterine growth restriction</z:hpo> had anti-ProtS more frequently than the control group (36%, 47% and 44% vs. 4%; OR 13.6 [95% CI 2.8-66], p=0.003, OR 21 [95% CI 5-86], p&lt;0.0001 and OR 19 [95% CI 4-99], p=0.0014, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>Plasma levels of free protein S were not statistically different between patients with and without anti-ProtS and controls (77.9% [20.7-100] vs. 83.7% [52.7-100] vs. 89% [62-101], respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>Free protein S functional activity was no different between subgroups (105% [48-230] in anti-ProtS positive vs. 123% [95-283] in anti-ProtS negative vs. 136% [60-174] in controls) </plain></SENT>
<SENT sid="10" pm="."><plain>Anti-ProtS are frequent in SLE patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> and pregnancy morbidity </plain></SENT>
<SENT sid="11" pm="."><plain>These antibodies do not interfere with free protein S in plasma since its level and/or functional activity are not impaired </plain></SENT>
</text></document>